Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Sex Health ; 212024 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-38522475

RESUMO

BACKGROUND: Conversations around disease conducted through social media provide a means for capturing public perspectives that may be useful in considering public health approaches. Syphilis is a sexually transmitted disease that is re-emerging. We sought to characterise online discourse on syphilis using data collected from the social media platform, Twitter. METHODS: We extracted English-language tweets containing the word 'syphilis' posted on Twitter in 2019. Tweet identification number and URL, date and time of posting, number of retweets and likes, and the author's screen name, username and biographical statement were included in the dataset. A systematically sampled 10% subset of the data was subjected to qualitative analysis, involving categorisation on content. All tweets assigned to the category of medical resource were assessed for clinical accuracy. The engagement ratio for each category was calculated as (retweets+likes):tweets. RESULTS: In 2019, 111,388 tweets mentioning syphilis were posted by 69,921 authors. The most frequent content category - totalling 5370 tweets (48%) - was a joke. Of 1762 tweets (16%) categorised as a medical resource, 1484 (84%) were medically correct and 240 (14%) were medically incorrect; for 38 (2%), medical accuracy could not be judged from the information posted. Tweets categorised as personal experiences had the highest engagement ratio at approximately 19:1. Medical resource tweets had an engagement ratio of approximately 7:1. CONCLUSIONS: We found medical information about syphilis was limited on Twitter. As tweets about personal experiences generate high engagement, coupling an experience with information may provide opportunity for public health education.


Assuntos
Infecções Sexualmente Transmissíveis , Mídias Sociais , Sífilis , Humanos , Sífilis/diagnóstico , Comunicação , Saúde Pública
2.
Clin Infect Dis ; 75(8): 1467-1480, 2022 10 12.
Artigo em Inglês | MEDLINE | ID: mdl-35438780

RESUMO

Cytomegalovirus (CMV) is the leading infectious cause of congenital neurological disabilities. Valacyclovir and CMV hyperimmune globulin (HIG) may reduce vertical transmission and sequelae in neonates. A systematic review on valacyclovir and CMV HIG in preventing vertical transmission or reducing sequelae in neonates was conducted to 3 September 2021. Valacyclovir as a preventive strategy was supported by a well-conducted randomized controlled trial. Evidence supporting valacyclovir as a treatment strategy was limited to observational studies at moderate risk of bias. CMV HIG was not supported as a preventive strategy in 2 randomized controlled trials, which contrasted with observational studies. Evidence favoring CMV HIG as a treatment strategy was limited to observational studies at moderate risk of bias. The role of valacyclovir and CMV HIG in CMV infection in pregnancy is still being defined. Valacyclovir to prevent vertical transmission has the highest quality evidence in favor of use.


Assuntos
Infecções por Citomegalovirus , Doenças Fetais , Globulinas , Complicações Infecciosas na Gravidez , Citomegalovirus , Infecções por Citomegalovirus/tratamento farmacológico , Infecções por Citomegalovirus/prevenção & controle , Feminino , Humanos , Imunoglobulinas Intravenosas , Recém-Nascido , Transmissão Vertical de Doenças Infecciosas/prevenção & controle , Gravidez , Complicações Infecciosas na Gravidez/prevenção & controle , Ensaios Clínicos Controlados Aleatórios como Assunto , Valaciclovir/uso terapêutico
3.
Am J Nephrol ; 49(5): 400-409, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-30982041

RESUMO

BACKGROUND AND OBJECTIVES: Kidney disorders in pregnancy may be under-recognized and have variable impact on outcomes depending on diagnosis. Population-level data are limited, particularly for Australia, and comparison of impact of different kidney disorders on pregnancy has rarely been assessed. This study examined the prevalence and outcomes of varied kidney disorders using population-level perinatal data from a large cohort. METHODS: Women with singleton pregnancies > 20 weeks' gestation from the South Australian Pregnancy Outcomes Unit (1990-2012). Women with a kidney disorders diagnostic code were grouped into categories (immunological, cystic/genetic, urological, vesicoureteral reflux (VUR), pyelonephritis and "other"). Key pregnancy outcomes were assessed, with adjustment for demographic variables. RESULTS: Kidney disorders were reported in 1,392 (0.3%) of 407,580 births. These pregnancies had increased risk of pregnancy-induced hypertension (OR 2.16, 95% CI 1.82-2.56), induction of labor (RRR vs. spontaneous birth 2.10, 95% CI 1.87-2.36), all Caesarean section (OR 1.31, 95% CI 1.17-1.47) as well as Caesarean section without labor (RRR 1.82, 95% CI 1.57-2.10), preterm birth (< 37 weeks; 2.76, 95% CI 2.40-3.18), low birth weight (< 2,500 g) infants (OR 2.43, 95% CI 2.07-2.84), and neonatal intensive care admission (OR 2.64, 95% CI 2.12-3.29). Diagnostic subgroups demonstrated differing patterns of adverse outcomes, enabling the development of a matrix of risk. Women with immunological renal conditions and VUR had greatest risk overall, and only women with immunological diseases had increased risk of small-for-gestational age < 10th centile (OR 2.36, 95% CI 1.26-4.42). Women with nonchronic urological conditions and pyelonephritis had increased risk of preterm birth, but not other adverse events. VUR conferred particularly increased risk of Caesarean section and induced labor. CONCLUSIONS: In a cohort of > 1,300 women with varied kidney disorders, increased adverse obstetric and perinatal events were observed, and the nature and magnitude of risk differed according to diagnosis. In particular, vesicoureteric reflux is not a benign condition in pregnancy. Women with nonchronic conditions still had increased risk of preterm birth. We confirm that women with kidney disorders warrant vigilant and tailored prepregnancy care and clinical care in pregnancy.


Assuntos
Cesárea/estatística & dados numéricos , Hipertensão Induzida pela Gravidez/epidemiologia , Recém-Nascido de Baixo Peso , Nefropatias/epidemiologia , Nascimento Prematuro/epidemiologia , Refluxo Vesicoureteral/epidemiologia , Adulto , Austrália/epidemiologia , Feminino , Humanos , Hipertensão Induzida pela Gravidez/diagnóstico , Hipertensão Induzida pela Gravidez/etiologia , Recém-Nascido , Unidades de Terapia Intensiva Neonatal/estatística & dados numéricos , Nefropatias/complicações , Nefropatias/diagnóstico , Idade Materna , Pessoa de Meia-Idade , Admissão do Paciente/estatística & dados numéricos , Gravidez , Nascimento Prematuro/etiologia , Prevalência , Refluxo Vesicoureteral/complicações , Refluxo Vesicoureteral/diagnóstico , Adulto Jovem
5.
Biochim Biophys Acta ; 1835(2): 211-8, 2013 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-23287571

RESUMO

Heat shock protein 90 (Hsp90) is a molecular chaperone that regulates the maturation, activation and stability of critical signaling proteins that drive the development and progression of prostate cancer, including the androgen receptor. Despite robust preclinical data demonstrating anti-tumor activity of first-generation Hsp90 inhibitors in prostate cancer, poor clinical responses initially cast doubt over the clinical utility of this class of agent. Recent advances in compound design and development, use of novel preclinical models and further biological insights into Hsp90 structure and function have now stimulated a resurgence in enthusiasm for these drugs as a therapeutic option. This review highlights how the development of new-generation Hsp90 inhibitors with improved physical and pharmacological properties is unfolding, and discusses the potential contexts for their use either as single agents or in combination, for men with metastatic prostate cancer.


Assuntos
Proteínas de Choque Térmico HSP90/antagonistas & inibidores , Neoplasias da Próstata/tratamento farmacológico , Descoberta de Drogas , Proteínas de Choque Térmico HSP90/fisiologia , Humanos , Masculino
7.
PLoS Negl Trop Dis ; 11(12): e0006081, 2017 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-29232385

RESUMO

Bangladesh has made significant progress towards elimination of visceral leishmaniasis, and is on track to achieve its target of less than one case per 10,000 inhabitants in each subdistrict in 2017. As the incidence of disease falls, it is likely that the political capital and financial resources dedicated towards the elimination of visceral leishmaniasis may decrease, raising the prospect of disease resurgence. Policy memos may play a crucial role during the transition of the elimination plan from the 'attack' to the 'consolidation' and 'maintenance' phases, highlighting key stakeholders and areas where ongoing investment is crucial. An example of a policy brief is outlined in this paper. The background to the current elimination efforts is highlighted, with emphasis on remaining uncertainties including the impact of disease reservoirs and sustainable surveillance strategies. A stakeholder map is provided outlining the current and projected future activities of key bodies. Identification of key stakeholders subsequently frames the discussion of three key policy recommendations in the Bangladeshi context for the transition to the consolidation and maintenance phases of the elimination program. Recommendations include determining optimal vector control and surveillance strategies, shifting the emphasis towards horizontal integration of disease programs, and prioritising remaining research questions with a focus on operational and technical capacity. Achieving elimination is as much a political as a scientific question. Integrating the discussion of key stakeholders with policy priorities and the research agenda provides a novel insight into potential pathways forwards in the elimination of visceral leishmaniasis in Bangladesh and in the rest of the Indian subcontinent.


Assuntos
Controle de Doenças Transmissíveis/organização & administração , Erradicação de Doenças/organização & administração , Leishmaniose Visceral/epidemiologia , Leishmaniose Visceral/prevenção & controle , Bangladesh/epidemiologia , Financiamento de Capital , Monitoramento Epidemiológico , Política de Saúde , Humanos
8.
Int J Womens Health ; 8: 273-85, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27471410

RESUMO

Parenthood is a central focus for women with chronic kidney disease, but raises important fears and uncertainties about risks to their own and their baby's health. Pregnancy in women with background kidney disease, women receiving dialysis, or those with a functioning kidney transplant poses a challenging clinical scenario, associated with high maternal-fetal morbidity and potential impact on maternal renal health. Improvements in care over recent decades have led to a paradigm shift with cautious optimism and growing interest regarding pregnancies in women with chronic kidney disease. In this review, we discuss obstetric and renal outcomes, and practical aspects of management of pregnancy in this complex cohort.

9.
Pediatrics ; 138(6)2016 12.
Artigo em Inglês | MEDLINE | ID: mdl-27940669

RESUMO

BACKGROUND: Although children born very preterm (gestation <32 weeks) have an increased risk of cognitive impairment compared with full-term children (39-41 weeks), the risk for children born moderately (32-33 weeks) to late preterm (34-36 weeks) and early term (37-38 weeks) is unclear. This study describes the relationship between gestational age and cognitive outcomes at 11 years and the trajectory of deficits in verbal ability from age 3 to 11 years. METHODS: Cognitive ability was assessed by using the Spatial Working Memory test from the Cambridge Neuropsychological Test Automated Working Battery (n = 11 395) and British Ability Scale Verbal Similarities test (n = 11 889) in the UK Millennium Cohort Study. Each gestational group was compared with the full-term group by using differences in z scores and odds ratios for delay (scoring ≥1 SD below the mean). RESULTS: Very and moderately preterm children demonstrated significantly lower working memory scores compared with full-term children (adjusted difference -0.2 to -0.6) and were more likely to be delayed. There was no significant relationship between late-preterm or early-term birth and working memory (adjusted differences < -0.1), or between gestational age and verbal ability at 11 years. There appears to be a general attenuation in odds ratios as the child ages. CONCLUSIONS: Very preterm children exhibited working memory deficits at 11 years. However, the absence of delayed verbal skills at 11 years despite earlier delays could indicate "catch-up" effects.


Assuntos
Transtornos Cognitivos/etiologia , Deficiências do Desenvolvimento/etiologia , Recém-Nascido Prematuro/psicologia , Desenvolvimento da Linguagem , Memória Espacial/fisiologia , Fatores Etários , Criança , Pré-Escolar , Transtornos Cognitivos/epidemiologia , Transtornos Cognitivos/fisiopatologia , Estudos de Coortes , Deficiências do Desenvolvimento/fisiopatologia , Feminino , Idade Gestacional , Humanos , Lactente Extremamente Prematuro/psicologia , Recém-Nascido , Estudos Longitudinais , Masculino , Razão de Chances , Gravidez , Valores de Referência , Medição de Risco , Fatores Sexuais , Reino Unido , Comportamento Verbal/fisiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA